Geneva, Switzerland and Boston, MA – 30 August, 2017 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics…
Month: August 2017
Q2 Report 2017
ObsEva at Wedbush PacGrow Healthcare Conference
Company Management will be presenting and holding one-on-one meetings at the Wedbush PacGrow Healthcare Conference. Date & Time: 16 August 2017 at…
ObsEva Reports Second Quarter 2017 Financial Results and Provides Business Update
– Patient Enrollment Progressing for late stage clinical programs in Assisted Reproductive Technology, Uterine Fibroids, and Endometriosis – Geneva, Switzerland and Boston,…
ObsEva SA to Hold Second Quarter 2017 Financial Results/Business Update Call on August 15, 2017 and Present at Wedbush PacGrow Healthcare Conference in NYC on August 16, 2017
Geneva, Switzerland and Boston, MA – 07 August, 2017 – ObsEva SA (NASDAQ: OBSV), a Swiss biopharmaceutical company focused on the development and commercialization of novel therapeutics…